These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7005847)

  • 21. Monoclonal and polyclonal antibodies compared for radioimmunoassay of somatomedin-C in patients with acromegaly or hypopituitarism.
    Burrin JM; Paterson JL; Sharp PS; Yeo TH
    Clin Chem; 1987 Sep; 33(9):1593-6. PubMed ID: 3621559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relation between growth velocity and serum somatomedin C concentration.
    Rudman D; Moffitt SD; Fernhoff PM; McKenzie WJ; Kenny JM; Bain RP
    J Clin Endocrinol Metab; 1981 Apr; 52(4):622-7. PubMed ID: 7193684
    [No Abstract]   [Full Text] [Related]  

  • 23. [Somatomedins and their significance in pediatrics].
    Vetter U; Teller WM
    Klin Padiatr; 1985; 197(5):378-85. PubMed ID: 3906254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The somatomedins: insulin-like growth factors.
    Baxter RC
    Adv Clin Chem; 1986; 25():49-115. PubMed ID: 2424282
    [No Abstract]   [Full Text] [Related]  

  • 25. Somatomedin-C/insulin-like growth factor-I as a modulator of growth during childhood and adolescence.
    Furlanetto RW; Cara JF
    Horm Res; 1986; 24(2-3):177-84. PubMed ID: 3530940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate.
    Rosenfeld RG; Kemp SF; Hintz RL
    J Clin Endocrinol Metab; 1981 Sep; 53(3):611-7. PubMed ID: 7021582
    [No Abstract]   [Full Text] [Related]  

  • 27. A radioimmunoassay for insulin-like growth factor II specific for the C-peptide region.
    Hintz RL; Liu F
    J Clin Endocrinol Metab; 1982 Feb; 54(2):442-6. PubMed ID: 6172444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of immunoreactive somatomedin C human serum by growth hormone: dose-response relationships and effect on chromatographic profiles.
    Copeland KC; Underwood LE; Van Wyk JJ
    J Clin Endocrinol Metab; 1980 Apr; 50(4):690-7. PubMed ID: 7189195
    [No Abstract]   [Full Text] [Related]  

  • 29. [Somatomedin and growth].
    Ranke MB
    Monatsschr Kinderheilkd; 1985 Jun; 133(6):336-42. PubMed ID: 3900698
    [No Abstract]   [Full Text] [Related]  

  • 30. Prolactin and somatomedin in hypopituitary patients with "catch up" growth following operations for craniopharyngioma.
    Kenny FM; Guyda HJ; Wright JC; Friesen HG
    J Clin Endocrinol Metab; 1973 Feb; 36(2):378-80. PubMed ID: 4683190
    [No Abstract]   [Full Text] [Related]  

  • 31. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance.
    Hardouin S; Gourmelen M; Noguiez P; Seurin D; Roghani M; Le Bouc Y; Povoa G; Merimee TJ; Hossenlopp P; Binoux M
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1291-301. PubMed ID: 2555386
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease.
    Kirschner BS; Sutton MM
    Gastroenterology; 1986 Oct; 91(4):830-6. PubMed ID: 3743961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy.
    Hintz RL; Liu F; Rosenfeld RG; Kemp SF
    J Clin Endocrinol Metab; 1981 Jul; 53(1):100-4. PubMed ID: 6165729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatomedin levels in cerebrospinal fluid from adults with pituitary disorders.
    Bäckström M; Hall K; Sara V
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):171-8. PubMed ID: 6388207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperprolactinemia is associated with increased immunoreactive somatomedin C in hypopituitarism.
    Clemmons DR; Underwood LE; Ridgway EC; Kliman B; Van Wyk JJ
    J Clin Endocrinol Metab; 1981 Apr; 52(4):731-5. PubMed ID: 7193685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The presence of normal levels of serum immunoreactive insulin-like growth factor 2 (IGF-2) in patients with Down's syndrome.
    Annerén G; Enberg G; Sara VR
    Ups J Med Sci; 1984; 89(3):274-8. PubMed ID: 6240148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma somatomedin-C as a screening test for growth hormone deficiency in children and adolescents.
    Moore DC; Ruvalcaba RH; Smith EK; Kelley VC
    Horm Res; 1982; 16(1):49-55. PubMed ID: 7200069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient enhancement of serum somatomedin levels prior to weaning of growth-impaired vasopressin-deficient Brattleboro rats.
    Boer GJ; Hall K; Sara VR
    J Dev Physiol; 1985 Oct; 7(5):321-7. PubMed ID: 4056338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Age- and sex-related variations in the serum concentration of somatomedin C in normal children and adults].
    Giwercman B; Giwercman A; Kastrup KW; Skakkebaek NE
    Ugeskr Laeger; 1987 May; 149(20):1320-3. PubMed ID: 3603776
    [No Abstract]   [Full Text] [Related]  

  • 40. Correlation between somatomedin A in serum and body height development in healthy children and children with certain growth disturbances.
    Hall K; Filipsson R
    Acta Endocrinol (Copenh); 1975 Feb; 78(2):239-50. PubMed ID: 1172897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.